Prevalence and Genetic Alternation of Autoimmune Polyglandular Syndrome Type II in Taiwan
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
Autoimmune polyendocrine syndrome (APS) is an autoimmune disease involving at least two endocrine organ. It is classified into type I and type II diseases. Among them, APS type II is more common. It is diagnosed when two of the three following diseases are diagnosed in the same patient, including type 1 diabetes mellitus, autoimmune thyroid disease, and primary adrenal insufficiency. In this study, we will observe the epidemiology, clinical characteristics, and genetic variants of APS II in Taiwan.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Healthy Volunteers: f
View:
• Patients visited NTUH during 2006-2021, and had at least two of the three diseases: type 1 DM, primary adrenal insufficiency, and autoimmune thyroid disease.
Locations
Other Locations
Taiwan
National Taiwan University Hospital
RECRUITING
Taipei
Contact Information
Primary
Shyang-Rong Shih, MD, PhD
srshih@ntu.edu.tw
+886-972653337
Time Frame
Start Date: 2022-01-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 650
Treatments
Autoimmune polyendocrine syndrome type II
patients with autoimmune polyendocrine syndrome type II
Related Therapeutic Areas
Sponsors
Leads: National Taiwan University Hospital